Macular Degeneration Research
AMD Clinical TrialsInformation on macular degeneration clinical trials are available at the National Institutes of Health website. It lists not only studies in the U.S. but internationally as well.There are different phases of studies as well as strict criteria to be eligible to be in a macular degeneration study. Learn more about how clinical trials work and if you may be eligible to be in one:
Macular Degeneration Clinical Trials
Macular Degeneration Treatment BreakthroughThe COMPLETE study may prove to be a macular degeneration breakthrough. This study is looking at treating the actual cause of macular degeneration. Philip J. Rosenfeld, MD, PhD is a Professor of Ophthalmology at the Bascom Palmer Eye Institute in Miami, Florida.As the principle investigator for this clinical trial he has shed some light on AMD clinical trials and more specifically how this macular degeneration study looks at the factors that may cause this retinal disease. To read our exclusive interview with Dr. Rosenfeld click here:
Macular Degeneration Treatment Breakthrough Wet Macular Degeneration Clinical TrialsMacular degeneration clinical trials for wet macular degeneration treatment involve many different treatment options. There are studies looking at new combinations of existing treatment - such as anti-VEGF injections and photodynamic therapy.Other studies are looking at radiation therapy in conjunction with macular degeneration medication or injections. To see what's available for wet macular degeneration research click here: Wet Macular Degeneration Clinical Trials Eccentric Viewing or Preferred Retinal Location - December 2008
Macular degeneration research also involves the better use of the vision a person does have through using their peripheral vision.The December edition of the Journal of Restorative Neurology and Neuroscience reports that "Reorganization of visual processing is related to eccentric viewing in patients with macular degeneration." In other words when macular degeneration patients compensate for their loss of central vision by using their peripheral vision or what is called a Preferred Retinal Location (where there are healthy photoreceptor cells), the brain reorganizes as well. There seems to be a reorganization in the visual cortex. This knowledge may lead to the development of more effective rehabilitation programs or tools to enhance the of those with AMD. It may also suggest that earlier intervention of eccentric viewing rehabilitation for those with early stage AMD may help promote this cortical reorganization earlier. To read more about Eccentric Viewing click here: Eccentric Viewing Low Glycemic Carbs and AMD
Macular Degeneration Research and Low Glycemic Carbs
According to Allen Taylor, Ph.D. and a team of scientists from Tufts University there may be a correlation between eating food with a high glycemic index and and increased risk or progression of macular degeneration. The team analyzed dietary data from over 4,000 people who participated in the National Eye Institute's Age-Related Eye Disease Study (AREDS). Their conclusion found there to be a connection between eating foods with a high glycemic index and an increased risk of developing or worsening macular degeneration. Another study of 600 individuals by Dr. Taylor, an Australian study as well have all reported the same findings. Low glycemic carbs are part of a healthy macular degeneration diet and an anti-inflammatory diet. To learn what kinds of food have a high glycemic index and what foods have a low glycemic index click here: low glycemic carbs Dry Macular Degeneration Clinical TrialsDry macular degeneration clinical trials are becoming more available as new treatments and earlier intervention is being researched. Dry Macular Degeneration Clinical TrialsAge Related Eye Disease Study 2AREDS 2This is a multi-center randomized trial of approximately 4,200 participants. One of the objectives of this trial is to "study the effects of high supplemental doses of the dietary xanthophylls (lutein and zeaxanthin) and omega -3 (DHA and EPA) on the development of advanced AMD."This macular degeneration clinical trial is no longer recruiting new participants but it is ongoing. Enrollment concluded in June 2008 and participants will be followed between five and six years. To learn more about this macular degeneration research click here AREDS 2 AREDS VitaminsThe Age Related Eye Disease Study was a major clinical trial sponsored by the National Institute of Health. Recruitment began in September 1990 and the first results were published in a press release in 2001.The results stated that the AREDS "found that taking high levels of antioxidants and zinc can reduce the risk of developing advanced age related macular degeneration by about 25%." NIH News Release Friday, October 12, 2001 To learn more about this study click here:
AREDS Vitamins
Go from Macular Degeneration Research to WebRN Macular Degeneration Home
Would you like to be updated on: √ The latest Macular Degneration Research? 
√ Prevention of Macular Degeneration?√ Tips for Daily Living? √ Food Suggestions for a Macular Degeneration Diet? √ Ideas on Visual Aids to Maximize your Sight? If you said "yes" to any of the above, sign up for my monthly Macular Degeneration News. New! CommentsShare your thoughts about what you just read! Leave a comment in the box below. |
